Mental Health Clinics in Mount Carmel, PA Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Judith Kriskie Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 129 E 5th St, Mount Carmel, PA 17851 Phone: 570-339-1828 Fax: 570-339-1924 |
Mount Carmel Mental Health Center Llc Psychologist Medicare: Not Enrolled in Medicare Practice Location: 129 E 5th St, Mount Carmel, PA 17851 Phone: 570-933-4179 Fax: 570-339-1924 |
Safety Net Counseling, Inc Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 N Vine St, Mount Carmel, PA 17851 Phone: 570-339-1119 Fax: 570-339-2824 |
Newton Psychiatric Clinic, L.l.c. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 129 E 5th St, Mount Carmel, PA 17851 Phone: 570-339-1828 Fax: 570-554-8701 |
News Archive
Nurse staffing levels, safety net status both factors in patient outcomes
A new study finds that higher nurse staffing levels can lead to better patient outcomes. However, the study also found this to not always be the case at safety net hospitals. Meanwhile, the Connecticut Mirror reports on hospitals' efforts to reduce readmissions. And, in other news, new research has found that patients are less likely to fill prescriptions when doctors specify brand names instead of allowing generic substitutions.
UT Southwestern researchers compare TVT and TOT sling procedures for stress urinary incontinence
As part of a national clinical trial, UT Southwestern Medical Center researchers found little difference in effectiveness between two popular treatments for one of the most common ailments among American women: stress urinary incontinence.
Taiho Pharmaceutical obtains approval in Japan for anticancer drug Lonsurf
Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug "Lonsurf(R) combination tablet T15, T20" (nonproprietary names: trifluridine and tipiracil hydrochloride; development code: TAS-102), for the treatment of patients with unresectable advanced or recurrent colorectal cancer (only if refractory to standard therapies).
New insights into SARS-CoV-2 viral diversity
The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.
› Verified 7 days ago